贲门失迟缓症扩张治疗术后应用循证护理的效果评价  

Evaluation of effect by evidence-based nursing applied after dilation therapy for achalasia of cardia

作　　者：张婷 黄妙英 

机构地区：[1]江门市人民医院,529000

出　　处：《中国实用医药》2017年第14期130-132,共3页China Practical Medicine

摘　　要：目的探讨贲门失迟缓症扩张治疗术后应用循证护理的效果。方法 70例行贲门失迟缓症扩张治疗的贲门失迟缓症患者,根据随机分配法分为观察组与对照组,各35例。对照组患者术后进行传统常规护理,观察组患者术后采用循证护理,比较两组患者行贲门失迟缓症扩张治疗术后并发症(穿孔、出血、疼痛、感染)发生率和患者护理满意度情况。结果两组患者穿孔、出血发生率比较差异无统计学意义(P>0.05)。观察组疼痛、感染发生率分别为65.71%、31.43%均明显低于对照组的88.57%、57.14%,差异具有统计学意义(P<0.05)。观察组患者护理满意度为97.14%,明显高于对照组的82.86%,差异具有统计学意义(P<0.05)。结论循证护理应用于贲门失迟缓症扩张治疗术后的护理,可显著降低并发症发生率,使患者满意度得到提高,可在临床护理中大力推广和使用。Objective To investigate effect by evidence-based nursing applied after dilation therapy for achalasia of cardia. Methods A total of 70 achalasia of cardia patients in dilation therapy were randomly divided into observation group and control group, with 35 cases in each group. The control group received postoperative conventional nursing alone, and the observation group received postoperative evidence-based nursing. Comparison was made on incidence of complications （perforation, hemorrhage, pain, infection） after dilation therapy for achalasia of cardia and nursing satisfaction degree between the two groups. Results There was no statistically significant difference of incidence of perforation and hemorrhage between the two groups （P〉0.05）. The observation group had incidence of pain and infection respectively as 65.71% and 31.43%, which were all much lower than $8.57% and 57.14% in the control group, and their difference had statistical significance （P〈0.05）. The observation group had obviously higher nursing satisfaction degree as 97.14% than 82.86% in the control group, and their difference had statistical significance （P〈0.05）. Conclusion Implement of evidence-based nursing in nursing after dilation therapy for achalasia of cardia can remarkably lower incidence of complications and improve total satisfaction degree in patients. This method is worth wide promotion and application in clinical nursing.

关 键 词：循证护理 贲门失迟缓症 并发症 

分 类 号：R-03[医药卫生] R473.6